Forigerimod, (Rigerimod) also known as Lupuzor, CEP-3345 for treatment of systemic lupus erythematosus (SLE)

New Drug Approvals

FORIGERIMOD

CHEMICAL NAMES
1. L-Tyrosine, L-arginyl-L-isoleucyl-L-histidyl-L-methionyl-L-valyl-L-tyrosyl-L-seryl-L-lysyl-L-arginyl-O-phosphono-L-serylglycyl-L-lysyl-L-prolyl-L-arginylglycyl-L-tyrosyl-L-alanyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-
2. O3,140-phosphono(human U1 small nuclear ribonucleoprotein 70 kDa (snRNP70))-(131-151)-peptide

MOLECULAR FORMULA C117H181N34O32PS
MOLECULAR WEIGHT 2639
TRADEMARK Lupuzor
SPONSOR Cephalon, Inc.
CODE DESIGNATION IPP 201101
CAS REGISTRY NUMBER 497156-60-2

STRUCTURAL FORMULA

stucture, http://www.ama-assn.org/ama1/pub/upload/mm/365/forigerimod.pdf

  1. Forigerimod nonproprietary drug name

    STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL. USAN. FORIGERIMOD.

    …………………………………………………………………………………………………………..

    FORIGERIMOD ACETATE

    CAS REGISTRY NUMBER 1160237-55-7  of acetate

    http://www.ama-assn.org/resources/doc/usan/forigerimod-acetate.pdf

     

  2. Forigerimod acetate nonproprietary drug name

    STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL. USAN. FORIGERIMOD ACETATE

    str is
    FORIGERIMOD ACETATE

Forigerimod, also known as Lupuzor or CEP-33457, (SyB L-1001) is a CD4 T-cell modulator being investigated for the treatment of systemic lupus erythematosus (SLE). In the Phase II trials, Lupuzor was administered subcutaneously at a dose of 200 mcg once a month for 3 months. The Phase III study is anticipated to…

View original post 534 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s